Venus Medtech (Hangzhou) Inc. (HKG:2500)
Hong Kong · Delayed Price · Currency is HKD 3.010
-0.370 (-10.95%)
At close: Jan 21, 2026
Venus Medtech (Hangzhou) Market Cap
Venus Medtech (Hangzhou) has a market cap or net worth of 1.32 billion as of January 21, 2026. Its market cap has decreased by -40.86% in one year.
Market Cap
1.32B
Enterprise Value
1.54B
Revenue
468.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.01
Market Cap Chart
Since December 10, 2019, Venus Medtech (Hangzhou)'s market cap has decreased from 16.91B to 1.32B, a decrease of -92.20%. That is a compound annual growth rate of -34.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 1.48B | 42.02% |
| Dec 31, 2025 | 1.04B | -83.31% |
| Dec 30, 2022 | 6.24B | -51.82% |
| Dec 31, 2021 | 12.96B | -61.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 291.88B |
| Hansoh Pharmaceutical Group Company | 260.32B |
| JD Health International | 215.66B |
| WuXi Biologics | 164.43B |
| Innovent Biologics | 155.25B |
| Sino Biopharmaceutical | 124.24B |
| CSPC Pharmaceutical Group | 112.39B |
| Akeso | 111.46B |